Our consultants understand many of the critical issues affecting the health and life sciences industry. This includes government health policy, the drug discovery and development process, manufacturing, supply chain management, transfer pricing, e-business, marketing and sales strategy, and changing consumer behaviors.

Companies in the health and life sciences industry face many challenges to build shareholder value. These issues include restructuring the drug discovery process to maximize the impact of bioinformatics and other drug discovery technologies, the challenges generic drug manufacturers pose to pioneer developers, HIPAA compliance, health care plan restructuring and the impact of cost containment, customization and pharmacogenomics implications on health care delivery and management, the disruptive effects of consumerism on management models, and the system wide impact of IT and communication technology.

Our clients include national and regional health systems, insurers, managed care organizations, pharmaceutical companies, hospitals, and academic medical centers.

The health care industry is entering a new phase, defined by: 

• Breakthroughs in the scientific understanding of disease and a new generation of discovery technologies that are revolutionizing drug development.
• Increasing consumer activism that is redefining the role of the consumer.
• The emergence of focused players at every point of the health care value chain, creating alternatives to vertical integration.

Capsicum Group, LLC can help you optimize expenditures through rigorous internal analysis of current marketing organizational structures, capabilities, cost structures and resource allocation, coupled with an external analysis of changing consumer purchasing patterns.